Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
Y. Zheng, E. T. Larragoite, J. Lama, I. Cisneros, J. C. Delgado, P. Slev, J. Rychert, E. A. Innis, E. S. C. P. Williams, M. Coiras, M. Rondina, A. M. Spivak, V. Planelles
Abstract
Antibody neutralization is an important prognostic factor in many viral diseases. To easily and rapidly measure titers of neutralizing antibodies in serum or plasma, we developed pseudovirion particles composed of the spike glycoprotein of SARS-CoV-2 incorporated onto murine leukemia virus capsids and a modified minimal MLV genome encoding firefly luciferase. These pseudovirions provide a practical means of assessing immune responses under laboratory conditions consistent with biocontainment level 2.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays
K. H. D. Crawford, R. Eguia, … J. D. Bloom·bioRxiv·Apr 20, 2020
- Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
H. Tani, L. Tan, … Y. Morinaga·bioRxiv·Aug 21, 2020
- SARS-CoV-2 Spike Pseudoviruses: A Useful tool to study virus entry and address emerging neutralization escape phenotypes
R. Kalkeri, Z. Cai, … F. Koide·bioRxiv·Jul 16, 2021
- Lentiviral vector-based SARS-CoV-2 pseudovirus enables analysis of neutralizing activity in COVID-19 convalescent plasma
C. Pamukcu, E. Celik, … T. Sutlu·bioRxiv·Dec 28, 2020
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
F. Schmidt, Y. Weisblum, … P. D. Bieniasz·bioRxiv·Jun 8, 2020
- Development and validation of IMMUNO-COV: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2
R. Vandergaast, T. Carey, … S. J. Russell·bioRxiv·May 26, 2020